These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1632845

  • 1. Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit--long-term antiatherogenic effect and effects on established plaques.
    Nagano Y, Nakamura T, Matsuzawa Y, Cho M, Ueda Y, Kita T.
    Atherosclerosis; 1992 Feb; 92(2-3):131-40. PubMed ID: 1632845
    [Abstract] [Full Text] [Related]

  • 2. Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Oshima R, Ikeda T, Watanabe K, Itakura H, Sugiyama N.
    Atherosclerosis; 1998 Mar; 137(1):13-22. PubMed ID: 9568732
    [Abstract] [Full Text] [Related]

  • 3. Prevention of atherosclerotic progression in Watanabe rabbits by probucol.
    Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Narumiya S, Kawai C.
    Am J Cardiol; 1988 Jul 25; 62(3):13B-19B. PubMed ID: 3394648
    [Abstract] [Full Text] [Related]

  • 4. Long-term probucol treatment reverses the severity of myocardial injury in watanabe heritable hyperlipidemic rabbits.
    Hoshida S, Yamashita N, Igarashi J, Aoki K, Kuzuya T, Hori M.
    Arterioscler Thromb Vasc Biol; 1997 Nov 25; 17(11):2801-7. PubMed ID: 9409258
    [Abstract] [Full Text] [Related]

  • 5. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Kleinveld HA, Demacker PN, Stalenhoef AF.
    Arterioscler Thromb; 1994 Aug 25; 14(8):1386-91. PubMed ID: 8049202
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hypercoagulable state in the Watanabe heritable hyperlipidemic rabbit, an animal model for the progression of atherosclerosis. Effect of probucol on coagulation.
    Mori Y, Wada H, Nagano Y, Deguchi K, Kita T, Shirakawa S.
    Thromb Haemost; 1989 Feb 28; 61(1):140-3. PubMed ID: 2749587
    [Abstract] [Full Text] [Related]

  • 8. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits.
    Daugherty A, Zweifel BS, Schonfeld G.
    Br J Pharmacol; 1991 May 28; 103(1):1013-8. PubMed ID: 1878742
    [Abstract] [Full Text] [Related]

  • 9. Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits.
    O'Brien K, Nagano Y, Gown A, Kita T, Chait A.
    Arterioscler Thromb; 1991 May 28; 11(3):751-9. PubMed ID: 2029510
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits.
    Witting P, Pettersson K, Ostlund-Lindqvist AM, Westerlund C, Wâgberg M, Stocker R.
    J Clin Invest; 1999 Jul 28; 104(2):213-20. PubMed ID: 10411551
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pravastatin decreases serum lipids and vascular cholesterol deposition in Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Khachadurian AK, Shimamura T, Rozovski SJ, Ananthakrishnan R, Armenian B, Coly E, alHinai A, Martucci C, Schneider SH, Amorosa LF.
    Jpn Heart J; 1991 Sep 28; 32(5):675-85. PubMed ID: 1774829
    [Abstract] [Full Text] [Related]

  • 15. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
    Carew TE, Schwenke DC, Steinberg D.
    Proc Natl Acad Sci U S A; 1987 Nov 28; 84(21):7725-9. PubMed ID: 3478721
    [Abstract] [Full Text] [Related]

  • 16. Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits.
    Kogushi M, Tanaka H, Ohtsuka I, Yamada T, Kobayashi H, Saeki T, Takada M, Hiyoshi H, Yanagimachi M, Kimura T, Yoshitake S, Saito I.
    Atherosclerosis; 1996 Aug 02; 124(2):203-10. PubMed ID: 8830933
    [Abstract] [Full Text] [Related]

  • 17. Cholesterol-fed heterozygous Watanabe heritable hyperlipidemic rabbits: a new model for atherosclerosis.
    Atkinson JB, Hoover RL, Berry KK, Swift LL.
    Atherosclerosis; 1989 Aug 02; 78(2-3):123-36. PubMed ID: 2783197
    [Abstract] [Full Text] [Related]

  • 18. Nifedipine suppressed atherosclerosis in cholesterol-fed rabbits but not in Watanabe heritable hyperlipidemic rabbits.
    Watanabe N, Ishikawa Y, Okamoto R, Watanabe Y, Fukuzaki H.
    Artery; 1987 Aug 02; 14(5):283-94. PubMed ID: 3662844
    [Abstract] [Full Text] [Related]

  • 19. [Prevention of atherosclerosis using an antioxidant].
    Ishii K, Kita T.
    Nihon Ronen Igakkai Zasshi; 1990 Mar 02; 27(2):177-81. PubMed ID: 2384991
    [Abstract] [Full Text] [Related]

  • 20. Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits.
    Braesen JH, Beisiegel U, Niendorf A.
    Virchows Arch; 1995 Mar 02; 426(2):179-88. PubMed ID: 7757289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.